Natural Killer Cell Large Granular Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Natural Killer Cell Large Granular Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-12-08Clinical Trial Update: Registry of the German CLL Study Group
Ongoing registry study by the German CLL Study Group recruiting participants for trials involving chronic lymphocytic leukemia, small lympho…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial is testing thalidomide for symptomatic large granular lymphocytic leukemia and related NK-LGL leukemia, currently r…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
Clinical trial update indicates a Phase 2 study of the JAK1 inhibitor golidocitnib for relapsed/refractory indolent T- and NK-cell lymphomas…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
This Phase 2 clinical trial is evaluating PI3K inhibitors for relapsed/refractory indolent T/NK-cell lymphomas and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
A clinical trial registry entry indicates that the National Longitudinal Cohort of Hematological Diseases focusing on Large Granular Lymphoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.